rs5498

This is a variant in the ICAM1 gene that changes a lysine to an glutamate.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

intercellular adhesion molecule 1 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele A
OR 1.19
p
N 10,708
Large GWAS
European
Allele A
OR 0.05
p 3.0e-37
N 9,268
Major Consortium StudyLarge GWAS
multi-ancestry
Sun BB et al. Genomic atlas of the human plasma proteome. Nature 558(7708):73-79 (2018)
Allele A
OR
β 1.200
p
N 3,301
Large GWAS
European

ICAM-1 measurement

Allele G
OR 1.28
p 4.0e-303
N 2,935
Large GWAS
Greater Middle Eastern (Middle Eastern, North African or Persian)
Allele G
OR 13.80
p 6.0e-89
N 22,435
Large GWAS
European
Allele G
OR 13.22
p 5.0e-25
N 4,570
Large GWAS
European
Allele G
OR 1.22
p 8.0e-267
N 997
Small GWAS
multi-ancestry
Allele G
OR 1.26
p 5.0e-64
N 466
Small GWAS
African American or Afro-Caribbean

intercellular adhesion molecule 5 measurement

Allele G
OR 0.51
p 2.0e-32
N 997
Small GWAS
multi-ancestry

neutrophil-to-lymphocyte ratio

Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele A
OR
p 4.0e-23
N 234,502
Large GWAS
European

lymphocyte count

Allele G
OR
p 1.0e-105
N 643,370
Large GWAS
multi-ancestry
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.03
p 1.0e-50
N 408,112
Large GWAS
European
Allele G
OR 0.04
p 1.0e-77
N 394,642
Large GWAS
European
Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele G
OR
p 3.0e-32
N 234,778
Large GWAS
European
Allele G
OR 0.04
p 7.0e-30
N 171,643
Large GWAS
European

ClinVar annotation

Benign
1 submitter

ICAM1-related disorder

View on ClinVar →

Research that mentions this SNP (2)

Genome‐wide association studies of cerebral white matter lesion burden
Meta-analysisN=12,385Fornage M. et al.(2011)· Annals of Neurology

Genome-wide meta-analysis of 9,361 Europeans identified six genome-wide significant SNPs on chromosome 17q25 associated with white matter hyperintensity (WMH) burden. The most significant SNP, rs3744028 (P = 4.0×10⁻⁹ discovery, P = 1.3×10⁻⁷ replication, P = 4.0×10⁻¹⁵ combined), and rs1055129 were replicated in 3,024 additional individuals. Risk alleles increased WMH burden by 4-8% of mean burden.

Traits studied:Cerebral white matter lesionsWhite matter hyperintensities (WMH) burden
ICAM gene cluster SNPs and prostate cancer risk in African Americans
AssociationN=677Hankui Chen et al.(2006)· Human Genetics

A case-control study in African American men (286 cases, 391 controls) confirmed that ICAM1 SNPs -9A/C (rs5490, OR=2.5) and K469E (rs5498, OR=1.8) are associated with prostate cancer risk in familial disease. A common ICAM haplotype containing the -9A/C variant was significantly associated with prostate cancer (P=0.03), particularly in men with family history. Unlike previous findings in European populations, ICAM5 SNPs were not associated with prostate cancer in African Americans.

Traits studied:Prostate cancer

About ICAM1

This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. [provided by RefSeq, Jul 2008]

View all ICAM1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…